Research and Markets (http://www.researchandmarkets.com/research/1cfcce/leukemia_drug_pipe)
has announced the addition of the "Leukemia
Drug Pipeline Update 2010" report to their offering.
Leukemia includes a broad variety of histological separate disorders
which make the leukemia market segmented.
There are today 222 (201) companies plus partners developing 280 (242)
leukemia drugs in 402 developmental projects in cancer. In addition, the
accumulated number of ceased drugs over the last years amount to another
84 (63) drugs. Leukemia Drug Pipeline Update lists all drugs and gives
you a progress analysis on each one of them. Identified drugs are linked
to 179 (148) different targets. These targets are further categorized on
the CD-ROM by 53 (46) classifications of molecular function and with
pathway referrals to BioCarta, KEGG and NetPath. Figures in brackets are
comparative data from last year.
Find and sort drugs by twelve different parameters plus free text search
field. Our dynamic report generator lets you with ease and speed
generate html reports directly in your web browser, whether it is a
single drug profile or an entire search you want have a report of.
How May Drug Pipeline Update Be of Use?